| Safety and Efficacy of HRS-9190 Compared to Rocuronium for Tracheal Intubation and Bolus Maintenance in Adults (NCT07746726) | Jiangsu HengRui Medicine Co., Ltd. | 2026-08-20 |
| A Trial of HRS-7085 Tablets in Patients With Moderate to Severe Active Ulcerative Colitis (NCT07760831) | Jiangsu HengRui Medicine Co., Ltd. | 2026-08-01 |
| A Clinical Study of HRS-7525 Tablets in Patients With Advanced Prostate Cancer (NCT07711184) | Jiangsu HengRui Medicine Co., Ltd. | 2026-07-30 |
| Phase I Study of HRS-3005 in B-cell Malignancies (NCT07556822) | Jiangsu HengRui Medicine Co., Ltd. | 2026-06-03 |
| A Trial of Trastuzumab Rezetecan in Unresectable Locally Recurrent/Metastatic Breast Cancer (NCT07497386) | Jiangsu HengRui Medicine Co., Ltd. | 2026-04-28 |
| A Study to Evaluate the Efficacy and Safety of Hetrombopag Olamine Tablets Vs Placebo in Patients With Chemotherapy-Induced Thrombocytopenia (NCT07286032) | Jiangsu HengRui Medicine Co., Ltd. | 2026-04-16 |
| Study on the Mass Balance of [14C]HRS-9190 for Injection in Healthy Participants (NCT07494175) | Jiangsu HengRui Medicine Co., Ltd. | 2026-04-11 |
| Safety and Efficacy of HRS-9190 Compared to Cisatracurium for Continuous Intravenous Infusion in Adults (NCT07446309) | Jiangsu HengRui Medicine Co., Ltd. | 2026-04-10 |
| A Clinical Study of SHR-4394 in Combination With Anti-tumor Therapy in Prostate Cancer (NCT07407283) | Jiangsu HengRui Medicine Co., Ltd. | 2026-04-08 |
| A Clinical Study Comparing the Relative Bioavailability and Safety of SHR-3167 Injection (NCT07489482) | Jiangsu HengRui Medicine Co., Ltd. | 2026-04-02 |
| A Clinical Study of HRS-8364 in the Treatment of Advanced Solid Tumor Subjects (NCT07446153) | Jiangsu HengRui Medicine Co., Ltd. | 2026-03-19 |
| A Clinical Study on the Safety, Tolerability, Pharmacokinetics and Efficacy of SHR-1049 in Patients With Advanced Solid Tumors (NCT07380334) | Jiangsu HengRui Medicine Co., Ltd. | 2026-03-12 |
| A Study of Bupivacaine Liposome Injection in the Treatment of Pain After Thoracoscopic Surgery (NCT06529432) | Jiangsu HengRui Medicine Co., Ltd. | 2026-03-03 |
| A Trial of Tegileridine Fumarate Lnjection for Prolonged Mechanical Ventilation Abirritation in the Intensive Care Unit (ICU) (NCT07372924) | Jiangsu HengRui Medicine Co., Ltd. | 2026-02-24 |
| The Efficacy and Safety of SHR4640 Tablet Combined With 40 mg Febuxostat Tablets in the Treatment of Primary Gout and Hyperuricemia (NCT07362355) | Jiangsu HengRui Medicine Co., Ltd. | 2026-02-09 |
| A Phase III Study Comparing HRS-4357 With Novel Androgen Receptor Pathway Inhibitors in Patients With Progressive, PSMA-Positive Metastatic Castration-Resistant Prostate Cancer (NCT07311694) | Jiangsu HengRui Medicine Co., Ltd. | 2026-02-02 |
| A Trial of SHR0302 Tablets and SHR0302 Base Gel in Patients With Non-segmental Vitiligo (NCT07251595) | Jiangsu HengRui Medicine Co., Ltd. | 2025-12-05 |
| A Phase III Clinical Study of Rezvilutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer (NCT07241416) | Jiangsu HengRui Medicine Co., Ltd. | 2025-12-05 |
| A Trial of HRS-4508 Combined With Other Antitumor Therapies in Subjects With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NCT07232849) | Jiangsu HengRui Medicine Co., Ltd. | 2025-12-04 |
| HRS 4642 Injection Combined With AG Versus Placebo Combined With AG Therapy in First-Line Advanced or Metastatic Pancreatic Cancer (NCT07232875) | Jiangsu HengRui Medicine Co., Ltd. | 2025-11-21 |
| A Phase II Clinical Study of FH-006 for Injection Combined With Other Anticancer Therapies in Subjects With Lung Cancer (NCT07241767) | Jiangsu HengRui Medicine Co., Ltd. | 2025-11-12 |
| Safety, Tolerability and Pharmacokinetic Studies of HRS-2183 for Injection in Healthy Chinese Subjects After Single and Multiple Administration (NCT07232758) | Jiangsu HengRui Medicine Co., Ltd. | 2025-10-30 |
| Safety and Efficacy of HRS-9190 Compared to Rocuronium for Tracheal Intubation in Adults (NCT07252921) | Jiangsu HengRui Medicine Co., Ltd. | 2025-10-30 |
| A Study of HRS-4508 in Combination With Other Anti-tumor Therapy for Solid Tumor (NCT07140393) | Jiangsu HengRui Medicine Co., Ltd. | 2025-10-28 |
| A Trial of SHR-A1811 Compared to Other Antitumor Therapies as Neoadjuvant Treatments in Early-stage or Locally Advanced HER2-positive Breast Cancer (NCT07196774) | Jiangsu HengRui Medicine Co., Ltd. | 2025-10-23 |
| A Study of HRS-2329 in Participants With Advanced Solid Tumors Harboring RAS Mutations or Amplifications (NCT07189949) | Jiangsu HengRui Medicine Co., Ltd. | 2025-10-16 |
| A Phase II Trial of SHR-A1811 in HER2-Expressing Recurrent/Metastatic Cervical Cancer (NCT07051486) | Jiangsu HengRui Medicine Co., Ltd. | 2025-10-11 |
| Phase II Clinical Study of SHR2554 Tablets Combined With Other Anti-tumor Treatments in Non-small Cell Lung Cancer Subjects (NCT07175220) | Jiangsu HengRui Medicine Co., Ltd. | 2025-10-09 |
| A Phase I Study of HRS-7172 in Participants With Advanced Solid Tumors Harboring RAS Mutations or Amplifications (NCT07142980) | Jiangsu HengRui Medicine Co., Ltd. | 2025-09-12 |
| A Trial of HRS-4508 in Subjects With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NCT07003321) | Jiangsu HengRui Medicine Co., Ltd. | 2025-09-12 |
| Safety and Efficacy of SHR2554 Combined With Other Antitumor Therapies in Gastric or Gastro-oesophageal Junction Adenocarcinoma (NCT07102901) | Jiangsu HengRui Medicine Co., Ltd. | 2025-09-05 |
| A Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenous Bolus and Infusion HRS-9190 in Healthy Adults (NCT07142850) | Jiangsu HengRui Medicine Co., Ltd. | 2025-08-26 |
| A Clinical Study to Evaluate the Pharmacokinetic and Pharmacodynamics Properties of of SHR-3167 in Subjects With Type 2 Diabetes (NCT07032688) | Jiangsu HengRui Medicine Co., Ltd. | 2025-08-11 |
| A Clinical Study to Evaluate the Safety and Pharmacokinetics of Topical RSS0393 Ointment in Children and Adolescents With Plaque Psoriasis (NCT07102888) | Jiangsu HengRui Medicine Co., Ltd. | 2025-08-01 |
| A Phase I/II Clinical Study of FH-006 for Injection in Patients With Malignant Solid Tumors (NCT07136142) | Jiangsu HengRui Medicine Co., Ltd. | 2025-08-01 |
| A Study Comparing SHR-3167 and Insulin Degludec in Type 2 Diabetic Subjects Treated With Basal Insulin With or Without Oral Antidiabetic Drugs (NCT07018453) | Jiangsu HengRui Medicine Co., Ltd. | 2025-07-16 |
| Effect of HRS-8427 for Injection on the Pharmacokinetics of Furosemide and Metformin in Healthy Subjects。 (NCT07073157) | Jiangsu HengRui Medicine Co., Ltd. | 2025-07-15 |
| A Trial of HRS-6213 in Healthy Subjects and Patients With Solid Tumors (NCT07070349) | Jiangsu HengRui Medicine Co., Ltd. | 2025-07-10 |
| A Trial of Remimazolam for Intraoperative Sedation in Pediatric and Adolescent Patients (NCT07036419) | Jiangsu HengRui Medicine Co., Ltd. | 2025-07-10 |
| A Comparative Pharmacokinetic Study of Single-Dose Administration of HR091506 Tablets From Different Batches in Healthy Subjects (NCT07076459) | Jiangsu HengRui Medicine Co., Ltd. | 2025-07-10 |
| Phase I/II Clinical Study of HRS-1738 for the Diagnosis of Prostate Cancer Patients (NCT07056439) | Jiangsu HengRui Medicine Co., Ltd. | 2025-07-01 |
| Pharmacokinetics Impact of HRS-8427 on Bupropion and Midazolam in Healthy Subjects (NCT07049107) | Jiangsu HengRui Medicine Co., Ltd. | 2025-06-23 |
| A Study to Evaluate the Effect of Rifampicin on the Pharmacokinetics of Oral HRS-5041 in Healthy Subjects (NCT07014488) | Jiangsu HengRui Medicine Co., Ltd. | 2025-06-20 |
| A Study on the Bioequivalence of Bupivacaine Liposome Injection in Humans (NCT07279155) | Jiangsu HengRui Medicine Co., Ltd. | 2025-06-09 |
| A Study of Linperlisib (YY-20394) in Combination With Rituximab in Patients With Relapsed/Refractory Indolent NHL (NCT06981988) | Jiangsu HengRui Medicine Co., Ltd. | 2025-06-01 |
| A Clinical Study of HRS-6209 Combined With Other Treatment Regimens in Patients With Breast Cancer (NCT06974929) | Jiangsu HengRui Medicine Co., Ltd. | 2025-05-22 |
| Study on the Mass Balance of [14C]HRS-8427 for Injection in Healthy Chinese Subjects (NCT07049562) | Jiangsu HengRui Medicine Co., Ltd. | 2025-05-21 |
| A Trial of SHR7280 in Healthy Subjects (NCT06969664) | Jiangsu HengRui Medicine Co., Ltd. | 2025-05-19 |
| A Phase 1 Clinical Study to Evaluate the Effects of SHR7280 on the Pharmacokinetics of Midazolam, S-warfarin, Omeprazole, Digoxin, and Rosuvastatin in Healthy Subjects (NCT06949124) | Jiangsu HengRui Medicine Co., Ltd. | 2025-04-28 |
| A Trial of HRS-6768 in Patients With Advanced Solid Tumors (NCT06925581) | Jiangsu HengRui Medicine Co., Ltd. | 2025-04-24 |
| A Study to Evaluate the Safety, Tolerability and Dose-Response Relationship of HRS-9190 in Healthy Subjects (NCT06932315) | Jiangsu HengRui Medicine Co., Ltd. | 2025-04-23 |
| A Study of SHR-9803 for Injection in Patients With Advanced Solid Tumors (NCT06906731) | Jiangsu HengRui Medicine Co., Ltd. | 2025-04-01 |
| To Evaluate the Efficacy and Safety of RSS0393 Ointment in Patients With Plaque Psoriasis Phase II Study (NCT06918743) | Jiangsu HengRui Medicine Co., Ltd. | 2025-04-01 |
| Study of SHR-1209 Administered by Single-site or Multiple-site Subcutaneous Injections in Healthy Volunteers (NCT06837077) | Jiangsu HengRui Medicine Co., Ltd. | 2025-03-14 |
| A Study of SHR-A1811 in Subjects With Ovarian Cancer (NCT06828354) | Jiangsu HengRui Medicine Co., Ltd. | 2025-03-13 |
| Investigation of Drug-drug Interaction of Ritonavir and Itraconazole on the Pharmacokinetics of SHR-A1811 in Subjects With HER2-expressing Advanced Breast Cancer (NCT06710990) | Jiangsu HengRui Medicine Co., Ltd. | 2025-02-17 |
| A Trial of SHR0302Base in Patients With Vitiligo (NCT06790862) | Jiangsu HengRui Medicine Co., Ltd. | 2025-02-13 |
| A Study of SHR-4394 Injection in Subjects With Prostate Cancer (NCT06783829) | Jiangsu HengRui Medicine Co., Ltd. | 2025-01-22 |
| Efficacy and Safety of SHR-3167 and Insulin Glargine in Type 2 Diabetes Subjects (NCT06688123) | Jiangsu HengRui Medicine Co., Ltd. | 2025-01-08 |
| Phase I/II Clinical Study of FH-006 for Injection in Patients With Malignant Solid Tumors (NCT06735144) | Jiangsu HengRui Medicine Co., Ltd. | 2024-12-23 |
| A Study for the Treatment of Metastatic Prostate Cancer With HRS-1167 Tablets Combined With Abiraterone Acetate Tablets and Prednisone (NCT06689163) | Jiangsu HengRui Medicine Co., Ltd. | 2024-12-11 |
| A Study for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Brain and/or Spinal Cord Conditions (NCT06731829) | Jiangsu HengRui Medicine Co., Ltd. | 2024-12-01 |
| A Study to Evaluate the Efficacy and Safety of HRG2010 in Parkinson's Disease With Motor Fluctuations (NCT06596876) | Jiangsu HengRui Medicine Co., Ltd. | 2024-11-06 |
| The Experiment of Noiiglutide Injection in Type 2 Diabetes Patients (NCT06649773) | Jiangsu HengRui Medicine Co., Ltd. | 2024-10-25 |
| A Clinical Study of the Safety, Tolerability, Pharmacokinetics, and Initial Efficacy of HRS-4508 Monotherapy in Patients With Advanced or Metastatic Solid Tumors (NCT06598735) | Jiangsu HengRui Medicine Co., Ltd. | 2024-09-30 |
| A Trial of HRS-8427 in the Treatment of Adults With Complicated Urinary Tract Infection, Including Acute Pyelonephritis (NCT06569056) | Jiangsu HengRui Medicine Co., Ltd. | 2024-09-25 |
| A Trial of HRS-6209 in Combination With Fulvestrant, Letrozole, HRS-8080, or HRS-1358 in Breast Cancer Patients (NCT06555068) | Jiangsu HengRui Medicine Co., Ltd. | 2024-08-12 |
| A Study of HRS-4642 in Combination With Antineoplastic Agents in Advanced Solid Tumors (NCT06520488) | Jiangsu HengRui Medicine Co., Ltd. | 2024-08-09 |
| SHR-4602 for Injection in Subjects With HER2-expressing or -Mutated Unresectable or Metastatic Solid Tumors (NCT06516926) | Jiangsu HengRui Medicine Co., Ltd. | 2024-08-08 |
| The Phase III Clinical Study of Herombopag for the Treatment of Thrombocytopenia in Chronic Liver Disease Patients Undergoing Elective Invasive Surgery (NCT06507436) | Jiangsu HengRui Medicine Co., Ltd. | 2024-07-31 |
| A Study of SHR-A1811 in First-line Treatment of Patients With Advanced or Metastatic Non-small Cell Lung Cancer With HER2 Mutations (NCT06430437) | Jiangsu HengRui Medicine Co., Ltd. | 2024-07-29 |
| A Randomized, Double-blind, Placebo-controlled Phase I Clinical Trial to Evaluate the Safety and Pharmacokinetic Profile of Single and Multiple Dose Escalation Topical Dermal Administration of SHR0302 Alkali Gel in Healthy Subjects (NCT07098117) | Jiangsu HengRui Medicine Co., Ltd. | 2024-06-19 |
| A Study to Evaluate the Mass Balance of [14C]SHR7280 in Healthy Adult Volunteers (NCT06408948) | Jiangsu HengRui Medicine Co., Ltd. | 2024-06-07 |
| Phase II Clinical Study of SHR-A1811 in Patients With HER2 Expression / Amplification of Locally Advanced Unresectable or Recurrent Metastatic Biliary Tract Cancer (NCT06413745) | Jiangsu HengRui Medicine Co., Ltd. | 2024-06-04 |
| Clinical Trial of HR091506 Tablets in Treatment of Gout With Hyperuricemia in Adults (NCT06414837) | Jiangsu HengRui Medicine Co., Ltd. | 2024-06-01 |
| A Study of Bupivacaine Liposome Injection in Local Analgesia of Pediatric Patients (NCT06344091) | Jiangsu HengRui Medicine Co., Ltd. | 2024-05-21 |
| A Trial Comparing HR17031 With Insulin Glargine in Patients With Type 2 Diabetes (NCT06871761) | Jiangsu HengRui Medicine Co., Ltd. | 2024-05-08 |
| Comparison of HR011408 and NovoRapid® in Subjects With Diabetics (NCT06375031) | Jiangsu HengRui Medicine Co., Ltd. | 2024-05-01 |
| A Study Comparing HR17031 With Insulin Glargine in Patients With Type 2 Diabetes (NCT06881264) | Jiangsu HengRui Medicine Co., Ltd. | 2024-04-30 |
| Phase I Clinical Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RSS0343 Tablets in Healthy Subjects After Single and Multiple Oral Administration and the Effect of Food on the Pharmacokinetics of RSS0343 (NCT07101965) | Jiangsu HengRui Medicine Co., Ltd. | 2024-04-07 |
| A Phase II Study of SHR2554 in Patients With Relapsed or Refractory Follicular Lymphoma (NCT06368167) | Jiangsu HengRui Medicine Co., Ltd. | 2024-04-01 |
| Study of the Food Effects of Herombopag Olamine Tablets in Healthy Subjects. (NCT06346925) | Jiangsu HengRui Medicine Co., Ltd. | 2024-04-01 |
| A Phase Ib/II Clinical Study of HRS-1167 in Combination With Bevacizumab in Patients With Recurrent Ovarian Cancer (NCT06308406) | Jiangsu HengRui Medicine Co., Ltd. | 2024-03-15 |
| A Study of Remimazolam Tosilate for Sedation in the ICU (NCT06222294) | Jiangsu HengRui Medicine Co., Ltd. | 2024-03-12 |
| Randomized, Double-blind, Placebo-controlled Study of RSS0393 Ointment in Healthy and Psoriatic Subjects (NCT06308393) | Jiangsu HengRui Medicine Co., Ltd. | 2024-03-01 |
| To Compare the Pharmacodynamics, Pharmacokinetics, Safety, and Tolerability Between SHR-3167 Injection and Glargine Insulin in Healthy Subjects (NCT07588906) | Jiangsu HengRui Medicine Co., Ltd. | 2024-02-26 |
| Gallium (68Ga) Edotreotide PET/CT for Imaging Patients With Gastrointestinal Pancreatic Neuroendocrine Tumors (NCT06091748) | Jiangsu HengRui Medicine Co., Ltd. | 2024-02-22 |
| SHR2554 Clinical Study of Chidamide in the Treatment of T-cell Lymphoma (NCT06122389) | Jiangsu HengRui Medicine Co., Ltd. | 2024-02-05 |
| A Trial of HHPG-19K Injection and Auto-HHPG-19K Injection in Prevention of Chemotherapy-related Moderate to Severe Neutropenia of Patients With Nonmyeloid Malignancies (NCT06254742) | Jiangsu HengRui Medicine Co., Ltd. | 2024-02-01 |
| A SHR0302 BA Study on Healthy Subjects (NCT06202612) | Jiangsu HengRui Medicine Co., Ltd. | 2024-01-16 |
| A Study to Assess the Efficacy and Safety of HRG2005 Inhalation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (NCT06035393) | Jiangsu HengRui Medicine Co., Ltd. | 2024-01-15 |
| Effect of Rifampicin on the Pharmacokinetics of HRS-1167 in Healthy Subjects (NCT06198556) | Jiangsu HengRui Medicine Co., Ltd. | 2024-01-14 |
| SHR-A1811 for Subjects With Her2-positive Gastric Cancer and Gastroesophageal Junction Adenocarcinoma After Progression on or After First-line Anti-HER2 Therapy-containing Regimen (NCT06123494) | Jiangsu HengRui Medicine Co., Ltd. | 2024-01-09 |
| PK Effects of SHR4640 on Repaglinide and Midazolam, and the Impact of SHR4640 on QT Interval (NCT06196580) | Jiangsu HengRui Medicine Co., Ltd. | 2024-01-04 |
| A Study of Remimazolam Tosilate for Sedation in Non-intubated Diagnostic and Therapeutic Procedures (NCT06216444) | Jiangsu HengRui Medicine Co., Ltd. | 2024-01-01 |
| Relative Bioavailability Study of HR19042 in Healthy Subjects (NCT06922305) | Jiangsu HengRui Medicine Co., Ltd. | 2023-12-27 |
| Assessment of Gastric Emptying by SHR20004 in Healthy Subjects (NCT06137469) | Jiangsu HengRui Medicine Co., Ltd. | 2023-12-26 |
| A Study of SHR2554 With Chemotherapy in Treatment-naïve Patients With Peripheral T-cell Lymphoma (NCT06173999) | Jiangsu HengRui Medicine Co., Ltd. | 2023-12-22 |
| Clinical Study of HR091506 Tablets in Treatment of Gout With Hyperuricemia in Adults (NCT06139393) | Jiangsu HengRui Medicine Co., Ltd. | 2023-12-14 |
| Bioequivalence Study of 2 Sizes of SHR4640 Tablets Orally in Healthy Subjects (NCT06168929) | Jiangsu HengRui Medicine Co., Ltd. | 2023-12-13 |